TRANSMEDICS GROUP INC (1TMDX.MI) Forecast, Price Target & Analyst Ratings

BIT:1TMDX • US89377M1099

Current stock price

87.2 EUR
-26.5 (-23.31%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TRANSMEDICS GROUP INC (1TMDX.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€125.44
+ 43.85% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Feb 25, 2026
Period
Q4 / 2025
EPS Estimate
$0.40
Revenue Estimate
158.67M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€125.44
Upside
+ 43.85%
From current price of €87.20 to mean target of €125.44, Based on 20 analyst forecasts
Low
€98.05
Median
€128.12
High
€152.00

Price Target Revisions

1 Month
-3.87%
3 Months
N/A

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for 1TMDX.MI. The average price target is 125.44 EUR. This implies a price increase of 43.85% is expected in the next year compared to the current price of 87.2.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1TMDX Current Analyst Rating1TMDX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

1TMDX Historical Analyst Ratings1TMDX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
83.00%
1TMDX.MI was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about 1TMDX.MI.
In the previous month the buy percentage consensus was at a similar level.
1TMDX.MI was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Feb 25, 2026
Period
Q4 / 2025
EPS Estimate
$0.40
Revenue Estimate
158.67M
Revenue Q2Q
30.46%
EPS Q2Q
110.35%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
0.45%
Revenue (3 Months)
N/A
EPS (1 Month)
1.89%
EPS (3 Months)
N/A

Next Earnings Summary

1TMDX.MI is expected to report earnings on 2/25/2026. The consensus EPS estimate for the next earnings is 0.4 EUR and the consensus revenue estimate is 158.67M EUR.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
1TMDX.MI revenue by date.1TMDX.MI revenue by date.
93.46M
208.86%		241.623M
158.53%		441.54M
82.74%		613.04M
38.84%		738.31M
20.43%		868.85M
17.68%		981.6M
12.98%		1.149B
17.05%
EBITDA
YoY % growth
1TMDX.MI ebitda by date.1TMDX.MI ebitda by date.
-27.96M
25.66%		8.662M
130.98%		57.254M
560.98%		148.16M
158.78%		175.45M
18.42%		233.56M
33.12%		380.05M
62.72%		481.34M
26.65%
EBIT
YoY % growth
1TMDX.MI ebit by date.1TMDX.MI ebit by date.
-31.44M
20.26%		485K
101.54%		37.496M
7,631.13%		104.02M
177.42%		125.82M
20.96%		175.48M
39.47%		229.7M
30.90%		342.62M
49.16%
Operating Margin
1TMDX.MI operating margin by date.1TMDX.MI operating margin by date.
-33.64%0.20%8.49%16.97%17.04%20.20%23.40%29.82%
EPS
YoY % growth
1TMDX.MI eps by date.1TMDX.MI eps by date.
-1.25
22.36%		-0.77
38.40%		1.01
231.17%		2.66
163.67%		2.93
10.09%		3.67
25.18%		4.41
20.07%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.40
110.35%		0.70
0.38%		0.85
-8.10%		0.66
0.28%		0.67
68.81%		0.93
32.89%		1.06
25.41%		1.03
55.42%		1.03
53.38%
Revenue
Q2Q % growth		158.67M
30.46%		174.52M
21.59%		189.2M
20.23%		176.78M
22.91%		186.46M
17.51%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		27.26M
-4.82%		41.468M
23.49%		47.654M
-3.60%		42.335M
-1.59%		49.485M
81.53%		N/AN/AN/AN/A
EBIT
Q2Q % growth		15.158M
75.44%		29.121M
6.11%		36.084M
-1.32%		26.15M
12.23%		24.844M
63.90%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1TMDX.MI Yearly Revenue VS Estimates1TMDX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
1TMDX.MI Yearly EPS VS Estimates1TMDX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
53.74%
EPS Next 5 Year
44.52%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
25.57%
Revenue Next 5 Year
21.23%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
87.46%
EBIT Next 5 Year
68.49%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TRANSMEDICS GROUP INC / 1TMDX.MI Forecast FAQ

What do analysts expect the price target to be for TRANSMEDICS GROUP INC (1TMDX.MI)?

20 analysts have analysed 1TMDX.MI and the average price target is 125.44 EUR. This implies a price increase of 43.85% is expected in the next year compared to the current price of 87.2.

Can you provide the upcoming earnings date for TRANSMEDICS GROUP INC?

TRANSMEDICS GROUP INC (1TMDX.MI) will report earnings on 2026-02-25, after the market close.

What are the consensus estimates for 1TMDX stock next earnings?

The consensus EPS estimate for the next earnings of TRANSMEDICS GROUP INC (1TMDX.MI) is 0.4 EUR and the consensus revenue estimate is 158.67M EUR.

How do analysts rate TRANSMEDICS GROUP INC (1TMDX.MI)?

The consensus rating for TRANSMEDICS GROUP INC (1TMDX.MI) is 83 / 100 . This indicates that analysts generally have a positive outlook on the stock.